Production of medicines against cancer and diabetes has started in Iran, ONA’s Tehran bureau reports.
The presentation of medicines was held in Alborz province in the presence of Iranian VP for Science and Technology Sorena Sattari and Iranian Health Minister Saeed Namaki.
"Regorafenib" medicine against the cancer of bowels, stomach, and liver, “Sorafenib” medicine against the cancer of liver, kidney and thyroid and “Empagliflozin” and “Dapagliflozin” medicine for the treatment of diabetes.
The medicines were licensed by the Charter of the Science Board to the Food and Drug Administration (FDA).
Follow us on Telegram
t.me/apanewsaz
Follow us on Instagram
Follow us on Facebook
Follow us on Twitter
